Mirtazapine
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
71610-846 -
Package NDC
71610-846-15 -
Package NDC
71610-846-30 -
Package NDC
71610-846-45 -
Package NDC
71610-846-53 -
Application number
ANDA216751 -
SPL ID
1dffd745-a863-1f0e-e063-6394a90a1fff -
SPL set ID
1e0006b6-9405-95a7-e063-6294a90aa277 -
UNII
A051Q2099Q -
RxCUI
314111
What the source publishes
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Active ingredients
- Mirtazapine
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Mirtazapine",
"splId": "1dffd745-a863-1f0e-e063-6394a90a1fff",
"labels": [
{
"setId": "1e0006b6-9405-95a7-e063-6294a90aa277",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e0006b6-9405-95a7-e063-6294a90aa277",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1e0006b6-9405-95a7-e063-6294a90aa277"
}
],
"routes": [
"ORAL"
],
"labeler": "Aphena Pharma Solutions - Tennessee, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "15 TABLET, FILM COATED in 1 BOTTLE (71610-846-15)",
"package_ndc": "71610-846-15",
"identifierStatus": "well-formed",
"marketing_start_date": "20240717"
},
{
"sample": false,
"description": "30 TABLET, FILM COATED in 1 BOTTLE (71610-846-30)",
"package_ndc": "71610-846-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20240717"
},
{
"sample": false,
"description": "45 TABLET, FILM COATED in 1 BOTTLE (71610-846-45)",
"package_ndc": "71610-846-45",
"identifierStatus": "well-formed",
"marketing_start_date": "20240717"
},
{
"sample": false,
"description": "60 TABLET, FILM COATED in 1 BOTTLE (71610-846-53)",
"package_ndc": "71610-846-53",
"identifierStatus": "well-formed",
"marketing_start_date": "20240717"
}
],
"productId": "71610-846_1dffd745-a863-1f0e-e063-6394a90a1fff",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "71610-846",
"deaSchedule": null,
"genericName": "Mirtazapine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "MIRTAZAPINE",
"strength": "30 mg/1"
}
],
"applicationNumber": "ANDA216751",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230901",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"A051Q2099Q"
],
"rxcui": [
"314111"
],
"spl_set_id": [
"1e0006b6-9405-95a7-e063-6294a90aa277"
],
"manufacturer_name": [
"Aphena Pharma Solutions - Tennessee, LLC"
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:71610-846_1dffd745-a863-1f0e-e063-6394a90a1fff"